and institutional investors to raise $6 million to accelerate development of its novel IV-infused psilocin formulation TRP-8803. Tryptamine Therapeutics (ASX:TYP) said the placement was being ...

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

Rockville, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- According to a new industry report by Fact.MR, the global tryptamine API market is projected to be worth US$ 757.2 million in 2024 and thereafter ...

Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics is undergoing a strategic board reshuffle as Non-Executive Director Peter Molloy steps down, paving the way for Dr ...

Enveric Biosciences’ EVM301 portfolio receives five additional US patents: Cambridge, Massachusetts Wednesday, November 6, 2024, 17:00 Hrs [IST] Enveric Biosciences, a biotechno ...

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today ...

Several drug classes - including amphetamines, tryptamines, and psychedelics - have been shown to promote plasticity, however, these first-generation compounds may induce profound psychoactive ...

I spent three days going through Heart of Darkness with Rebind's AI reading platform. It felt like a book club for deep thinkers. Carly Quellman is a movement artist, storyteller and disability ...

It’s called “Party Politics,” but it’s not about those parties, or those politics. A novel within a novel fueled her hit thriller, “The Plot.” Keeping the stories straight was even ...

Functional gastrointestinal disorders are a range of disorders of the gastrointestinal tract for which there are no structural or biochemical abnormalities that can be found to explain the ...